Business Wire

IN-IAC

Share
The Indy Autonomous Challenge Returns to the Indianapolis Motor Speedway on September 6, 2024

The Indy Autonomous Challenge (IAC) will make a grand return to the Indianapolis Motor Speedway (IMS) “The Racing Capital of the World” on September 6th, 2024. The competition is set to be a landmark event, featuring a head-to-head race of the world’s fastest autonomous racecars piloted by AI driver software developed by 10 teams representing 18 top universities from North America, Europe, and Asia.

History was made at IMS in October 2021 when IAC organized the world’s first head-to-head high-speed autonomous racing competition. Since then, IAC has organized five races at iconic tracks, including Las Vegas Motor Speedway during CES and the Monza F1 Circuit in Italy. IAC and its university teams have achieved a long list of world records for high-speed ground-based autonomy. World records include the autonomous land speed record (192.2 mph), the top speed on-track (180 mph), the fastest on-track head-to-head overtake (177 mph), and most miles of autonomous racing (7,500 miles).

“Three years ago, we gathered the best and brightest minds from universities around the world to make history at Indianapolis Motor Speedway, proving that autonomous racing is possible and launching a global effort to accelerate the pursuit of high-speed autonomous mobility,” said Paul Mitchell, President of the Indy Autonomous Challenge. “After setting many records and proving that autonomous vehicles can race at extreme speeds, we are returning home to the Racing Capital of the World to attempt an even more ambitious head-to-head race.”

The upcoming race at IMS, which is being held in partnership with the Indiana Economic Development Corporation (IEDC), will be a high-adrenaline head-to-head race of multiple IAC AV-24 autonomous racecars. Teams from leading research universities worldwide will push the limits of autonomous technology, competing at breathtaking speeds on the iconic oval track. This race promises not just to entertain but to offer a glimpse into the future of mobility, where AI drivers can operate autonomous vehicles safely on highways at high speeds, reducing the risk of accidents and speeding up supply chain logistics.

“Indiana is a leader in the future of mobility, attracting new business investment, fostering R&D and inspiring innovation across EV, hydrogen and autonomy,” said Indiana Secretary of Commerce David Rosenberg. “The technologies, companies and talent being assembled by the Indy Autonomous Challenge are making significant strides in developing autonomous capabilities, putting Indiana at the forefront of tomorrow’s global economy while inspiring the next generation of leaders and risktakers.”

With 10 teams representing 18 universities from five countries, the race will be the world’s largest autonomous racing competition.

  • AI Racing Tech - University of California, Berkeley (California), with University of Hawai'i (Hawai’i), University of California, San Diego (California), and Carnegie Mellon University
  • Autonomous Tiger Racing - Auburn University (Alabama)
  • Black & Gold Autonomous Racing - Purdue University (Indiana)
  • Cavalier Autonomous Racing - University of Virginia (Virginia)
  • KAIST - Korea Advanced Institute of Science and Technology (South Korea)
  • Luddy Autonomous Racing – Indiana University (Indiana)
  • MIT-PITT-RW - Massachusetts Institute of Technology (Massachusetts), University of Pittsburgh (Pennsylvania), Rochester Institute of Technology (New York), and University of Waterloo (Canada)
  • PoliMOVE-MSU - Politecnico di Milano (Italy), Michigan State University (Michigan), University of Alabama (Alabama)
  • TUM Autonomous Motorsport - Technische Universität München (Germany)
  • UNIMORE Racing - University of Modena and Reggio Emilia (Italy)

“The Indianapolis Motor Speedway was originally built as a test bed for early automobiles,” said J. Douglas Boles, President of IMS. “Having teams from the world’s most elite research universities using the track to prove out the future of autonomous vehicles connects the track’s historic roots to the future of AI and robotics.”

The race will attract thousands of attendees from government, industry, and academia including 2,000 high school students studying Science, Technology, Engineering, and Math (STEM). The race event will be live-streamed worldwide for those who cannot attend in person.

“For many Hoosiers, your first trip to the Indianapolis Motor Speedway is a rite of passage,” said Indiana Secretary of Education Katie Jenner. “The Indy Autonomous Challenge provides a unique opportunity for students to visit the track and experience first-hand the incredible STEM technologies being developed right here in Indiana. We are excited to help recruit high school students to attend the event and partner in the planning of a STEM Zone that will connect them directly to future college and career opportunities.”

In addition to the “main event” head-to-head race, the day will include several interactive events and activations that will offer attendees a chance to learn about and engage with technologies of the future including autonomous vehicles, drones, robots, augmented and virtual reality, generative AI, sensor fusion, internet of things, etc. Activations will include:

  • Innovation Paddock: Interactive hard-tech exhibits by industry-leading companies, start-ups, universities, and innovation-based non-profits will be located in the Trackside Garages adjacent to the track. Here, attendees can interact with the latest technology advancements in mobility, AI, automation, robotics, and more.
  • Future Mobility Summit: An invitation-only summit centered around breakthrough advancements such as AI-driven autonomy, next-generation drones, smart infrastructure, and sustainable energy solutions, with a special focus on Indiana’s innovative contributions, the summit promises an unparalleled convergence of thought leaders from industry, government, and academia. This curated event, designed to spark meaningful discussions and foster policy development to accelerate the advent of future mobility, will feature dynamic keynotes and panel sessions steered by renowned figures from leading industry circles.
  • STEM Zone: Created in partnership with the Indiana Department of Education and dedicated to inspiring the next generation of innovators, the STEM Zone will engage students with interactive exhibits and educational sessions focused on science, technology, engineering, and mathematics underscoring the IAC's commitment to fostering curiosity and passion for STEM among youth, highlighting the critical role of education in the future of technology. Students will also have access to Innovation Paddock exhibitions, sponsored lunch concessions, and seating in the Tower Terrace Grandstands to watch the IAC race.

Companies, governments, universities, and non-profits interested in participating in the Indy Autonomous Challenge at IMS can contact info@indyautonomouschallenge.com. High School administrators or teachers interested in bringing students to the event can contact EEL@doe.in.gov. General attendees who would like to attend the race event can purchase tickets on the Indianapolis Motor Speedway website starting May 2nd, 2024.

About the IAC: The Indy Autonomous Challenge (IAC) is a non-profit corporation based in Indianapolis, Indiana (USA) which organizes racing competitions among university-affiliated teams representing 18 universities from around the world. Teams program AI drivers to pilot fully autonomous IAC racecars and compete in a series of history-making events at iconic tracks. Based in Indiana, the IAC is working to establish a hub for performance automation in the state and is harnessing the power of innovative competitions to attract the best and the brightest minds from around the globe to further state-of-the-art technology in safety and performance of automated vehicles. The IAC started as a $1 million prize competition with 31 university teams signing up to compete more than three years ago, representing top engineering and technology programs from 15 U.S. states and 11 countries. Follow the IAC @IndyAChallenge on LinkedIn, Twitter, Instagram, Facebook, & YouTube.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240502559440/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press release

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in

Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press release

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration

Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press release

Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release

First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye